Follow
Monty Silverdale
Monty Silverdale
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
60462008
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
A Williams, S Gill, T Varma, C Jenkinson, N Quinn, R Mitchell, R Scott, ...
The Lancet Neurology 9 (6), 581-591, 2010
8402010
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open …
PD Med Collaborative Group
The Lancet 384 (9949), 1196-1205, 2014
4122014
King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation
KR Chaudhuri, A Rizos, C Trenkwalder, O Rascol, S Pal, D Martino, ...
Movement Disorders 30 (12), 1623-1631, 2015
2592015
Gray’s anatomy: the anatomical basis of clinical practice
S Susan
Elsevier, 2015
2582015
Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial
Z Kefalopoulou, L Zrinzo, M Jahanshahi, J Candelario, C Milabo, M Beigi, ...
The Lancet Neurology 14 (6), 595-605, 2015
1732015
Small fiber neuropathy in Parkinson's disease: a clinical, pathological and corneal confocal microscopy study
L Kass-Iliyya, S Javed, D Gosal, C Kobylecki, A Marshall, IN Petropoulos, ...
Parkinsonism & related disorders 21 (12), 1454-1460, 2015
1492015
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study
F McGill, MJ Griffiths, LJ Bonnett, AM Geretti, BD Michael, NJ Beeching, ...
The Lancet Infectious Diseases 18 (9), 992-1003, 2018
1412018
EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
HS Dafsari, P Martinez‐Martin, A Rizos, M Trost, MG dos Santos Ghilardi, ...
Movement disorders 34 (3), 353-365, 2019
1402019
Discovery of volatile biomarkers of Parkinson’s disease from sebum
DK Trivedi, E Sinclair, Y Xu, D Sarkar, C Walton-Doyle, C Liscio, P Banks, ...
ACS central science 5 (4), 599-606, 2019
1342019
Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson's disease
HS Dafsari, P Reddy, C Herchenbach, S Wawro, JN Petry-Schmelzer, ...
Brain stimulation 9 (1), 78-85, 2016
1142016
Non-motor outcomes depend on location of neurostimulation in Parkinson’s disease
JN Petry-Schmelzer, M Krause, TA Dembek, A Horn, J Evans, K Ashkan, ...
Brain 142 (11), 3592-3604, 2019
1112019
A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
MA Silverdale, C Kobylecki, L Kass-Iliyya, P Martinez-Martin, M Lawton, ...
Parkinsonism & related disorders 56, 27-32, 2018
1042018
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
E Sinclair, DK Trivedi, D Sarkar, C Walton-Doyle, J Milne, T Kunath, ...
Nature communications 12 (1), 1592, 2021
992021
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐and long‐acting dopamine agonists
A Rizos, A Sauerbier, A Antonini, D Weintraub, P Martinez‐Martin, ...
European journal of neurology 23 (8), 1255-1261, 2016
932016
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease
MA Silverdale, S McGuire, A McInnes, AR Crossman, JM Brotchie
Experimental neurology 169 (2), 400-406, 2001
922001
Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: a randomized clinical trial
CE Clarke, S Patel, N Ives, CE Rick, F Dowling, R Woolley, K Wheatley, ...
JAMA neurology 73 (3), 291-299, 2016
912016
Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes
P Zis, P Martinez‐Martin, A Sauerbier, A Rizos, JC Sharma, PF Worth, ...
European journal of neurology 22 (8), 1145-1150, 2015
862015
Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate
MA Silverdale, C Kobylecki, PJ Hallett, Q Li, AW Dunah, P Ravenscroft, ...
Synapse 64 (2), 177, 2010
862010
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease
HS Dafsari, M Silverdale, M Strack, A Rizos, K Ashkan, P Mahlstedt, ...
Movement Disorders 33 (3), 421-430, 2018
822018
The system can't perform the operation now. Try again later.
Articles 1–20